May 9, 2013 | A new genetic test—Oncotype DX Genomic Prostate Score—purports to gauge the aggressiveness of prostate cancer, helping doctors and patients decide if they should their cancer right away or can safely monitor it. The test, and another one recently on the market, analyzes genes in a biopsy sample and gives a score for aggressiveness. Boston Herald